Literature DB >> 7681849

Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens.

C Ishida1, K Matsumoto, K Fukada, K Matsushita, H Shiraki, Y Maeda.   

Abstract

We have defined 10 linear immunogenic regions encoded by the putative hepatitis C virus (HCV) structural proteins (core and envelope) by employing an enzyme-linked immunosorbent assay (ELISA) and by using 17 sequential synthetic peptides covering the N-terminal 330 amino acids of the structural polyproteins as antigens. These peptides correspond to amino acids 1 to 24, 21 to 44, 42 to 68, 64 to 91, and 100 to 120 of the putative core protein and amino acids 192 to 212, 223 to 238, 236 to 258, 250 to 266, and 307 to 330 of the putative envelope protein. In particular, the peptide covering amino acids 21 to 44 of the core protein was reactive with all but one (40 of 41) of the serum samples giving a positive signal in the passive hemagglutination assay (PHA) using the core and nonstructural proteins (NS 3/4) of the virus as antigens. We detected the HCV genome in 25 (61%) of 41 PHA-positive serum samples by the polymerase chain reaction (PCR) test. Of 25 PCR-positive serum samples, 17 serum samples had reactivity to the peptides derived from the envelope protein. On the other hand, only 1 of the 16 PCR-negative serum samples had reactivity to the peptides derived from the envelope protein. Interestingly, we often observed high serum alanine aminotransferase levels in PCR-positive individuals bearing antibodies to the envelope protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681849      PMCID: PMC263590          DOI: 10.1128/jcm.31.4.936-940.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.

Authors:  T Miyamura; I Saito; T Katayama; S Kikuchi; A Tateda; M Houghton; Q L Choo; G Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

3.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  [Reference value of glutamic transaminase to prevent non-A non-B post-transfusion hepatitis].

Authors:  Y Irita; N Goto; M Kuribayashi; K Tokunaga; H Kiyokawa; Y Maeda; K Okochi
Journal:  Rinsho Byori       Date:  1989-10

5.  A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan.

Authors:  Y Kubo; K Takeuchi; S Boonmar; T Katayama; Q L Choo; G Kuo; A J Weiner; D W Bradley; M Houghton; I Saito
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

6.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus.

Authors:  W M Ching; C Wychowski; M J Beach; H Wang; C L Davies; M Carl; D W Bradley; H J Alter; S M Feinstone; J W Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

9.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  8 in total

1.  Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease.

Authors:  M Pirisi; P Ferroni; C Fabris; P Toniutto; G Soardo; D Vitulli; V Gasparini; E Bartoli
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

2.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system.

Authors:  Mei Peng; Chang-Bai Dai; Yuan-Ding Chen
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

4.  Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1.

Authors:  K Siemoneit; M da S Cardoso; K Koerner; A Wölpl; B Kubanek
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

5.  Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.

Authors:  Jean-Christophe Meunier; Rodney S Russell; Vera Goossens; Sofie Priem; Hugo Walter; Erik Depla; Ann Union; Kristina N Faulk; Jens Bukh; Suzanne U Emerson; Robert H Purcell
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

6.  Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.

Authors:  Z X Zhang; M Chen; A Sönnerborg; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

7.  Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.

Authors:  C T Yeh; C M Han; S Y Lo; J H Ou; K D Fan; I S Sheen; C M Chu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Antigenic structure of the hepatitis C virus envelope 2 protein.

Authors:  Z X Zhang; A Sönnerborg; M Sällberg
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.